Numerion Labs

San Francisco, US · 67 employees · 1 known investors

Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

AI & Machine LearningBiotechHealthtechMedical DevicesAI-powered Drug DiscoveryDeep LearningDrug discoveryOncologyin /atomwise/@atomwiseinc

Founders & leadership· Y Combinator alumni (W15)

Izhar WallachinFounder

Steve WorlandCEO

Pamela TsurudaVP, Biology

Mark SabatVP, Medicinal Chemistry

Kate StaffordVP, Machine Learning

Mike Varney

Robert Mittendorf

Adam Seabrook

Kemal Malik